318 related articles for article (PubMed ID: 23380727)
1. Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.
Reeves AZ; Campbell PJ; Sultana R; Malik S; Murray M; Plikaytis BB; Shinnick TM; Posey JE
Antimicrob Agents Chemother; 2013 Apr; 57(4):1857-65. PubMed ID: 23380727
[TBL] [Abstract][Full Text] [Related]
2. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):33. PubMed ID: 30008266
[TBL] [Abstract][Full Text] [Related]
4. Consequences of whiB7 (Rv3197A) mutations in Beijing genotype isolates of the Mycobacterium tuberculosis complex.
Köser CU; Bryant JM; Parkhill J; Peacock SJ
Antimicrob Agents Chemother; 2013 Jul; 57(7):3461. PubMed ID: 23761426
[No Abstract] [Full Text] [Related]
5. Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern India.
Kaur S; Rana V; Singh P; Trivedi G; Anand S; Kaur A; Gupta P; Jain A; Sharma C
Tuberculosis (Edinb); 2016 Jan; 96():96-101. PubMed ID: 26786660
[TBL] [Abstract][Full Text] [Related]
6. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
Zaunbrecher MA; Sikes RD; Metchock B; Shinnick TM; Posey JE
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20004-9. PubMed ID: 19906990
[TBL] [Abstract][Full Text] [Related]
8. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
Jugheli L; Bzekalava N; de Rijk P; Fissette K; Portaels F; Rigouts L
Antimicrob Agents Chemother; 2009 Dec; 53(12):5064-8. PubMed ID: 19752274
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
[TBL] [Abstract][Full Text] [Related]
10. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and molecular characterization of amikacin resistance among Mycobacterium tuberculosis clinical isolates from southern China.
Islam MM; Tan Y; Hameed HMA; Liu Y; Chhotaray C; Cai X; Liu Z; Lu Z; Wang S; Cai X; Su B; Li X; Tan S; Liu J; Zhang T
J Glob Antimicrob Resist; 2020 Sep; 22():290-295. PubMed ID: 32142951
[TBL] [Abstract][Full Text] [Related]
12. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
13. Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
Zhang Z; Liu M; Wang Y; Pang Y; Kam KM; Zhao Y
Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1959-66. PubMed ID: 24906439
[TBL] [Abstract][Full Text] [Related]
14. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
[TBL] [Abstract][Full Text] [Related]
15. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
Brossier F; Pham A; Bernard C; Aubry A; Jarlier V; Veziris N; Sougakoff W;
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895017
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis.
Via LE; Cho SN; Hwang S; Bang H; Park SK; Kang HS; Jeon D; Min SY; Oh T; Kim Y; Kim YM; Rajan V; Wong SY; Shamputa IC; Carroll M; Goldfeder L; Lee SA; Holland SM; Eum S; Lee H; Barry CE
J Clin Microbiol; 2010 Feb; 48(2):402-11. PubMed ID: 20032248
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Ogari CO; Nyamache AK; Nonoh J; Amukoye E
BMC Infect Dis; 2019 Mar; 19(1):279. PubMed ID: 30909867
[TBL] [Abstract][Full Text] [Related]
20. Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
Brossier F; Guindo D; Pham A; Reibel F; Sougakoff W; Veziris N; Aubry A
J Clin Microbiol; 2016 Jun; 54(6):1573-1580. PubMed ID: 27053671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
